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Whole-cell screening ofMycobacterium tuberculosis
(Mtb) remains a mainstay of drug discovery, but
subsequent target elucidation often proves difficult.
Conditional mutants that underexpress essential
genes have been used to identify compounds with
known mechanism of action by target-based whole-
cell screening (TB-WCS). Here, the feasibility of TB-
WCS in Mtb was assessed by generating mutants
that conditionally express pantothenate synthetase
(panC), diaminopimelate decarboxylase (lysA), and
isocitrate lyase (icl1). The essentiality of panC and
lysA, and conditional essentiality of icl1 for growth
on fatty acids, was confirmed. Depletion of PanC
and Icl1 rendered mutants hypersensitive to target-
specific inhibitors. Stable reporter strainsweregener-
ated for use in high-throughput screening, and their
utility was demonstrated by identifying compounds
that display greater potency against aPanC-depleted
strain. These findings illustrate the power of TB-WCS
as a tool for tuberculosis drug discovery.
INTRODUCTION
Tuberculosis (TB) remains the leading cause of death attribut-
able to a bacterial pathogen globally (Glaziou et al., 2009).
Although TB is treatable using the current arsenal of antituber-
cular drugs (Zhang, 2005), the therapeutic regimen is complex
and lengthy (Mitnick et al., 2009) and associated with poor
patient adherence. This, in turn, has promoted the selection of
Mycobacterium tuberculosis (Mtb) strains that are resistant to
one or more first-line drugs compounding the already daunting
challenge of global TB control. The case for developing new
and more effective drugs that have novel modes of action and
can shorten the duration of treatment is thus compelling (Koul
et al., 2011).844 Chemistry & Biology 19, 844–854, July 27, 2012 ª2012 Elsevier LExisting antitubercular drugs act on a limited repertoire of
molecular targets that are essential primarily for cell wall biosyn-
thesis, replication, transcription, or translation, and for which
resistance mechanisms have already emerged (Zhang and
Yew, 2009). As a consequence, the identification of compounds
that inhibit new biological targets and pathways is an important
goal. Genome-wide essentiality screens have yielded many
potential antimycobacterial targets (Lamichhane, 2010; Mdluli
and Spigelman, 2006); however, identifying small molecules
that inhibit such targets within the cellular environment remains
a challenge. On the one hand, inhibitors identified in target-
based biochemical screens frequently fail to exhibit activity
when tested against whole cells as a result of poor cell perme-
ability, efflux, metabolic redundancy in the pathway of interest,
and/or relative invulnerability of the target to inhibition (i.e., the
target is not rate limiting for the pathway) (Payne et al., 2007).
On the other hand, traditional whole-cell screens, which test
the activity of a library of compounds against live bacterial cells,
are limited by the inherent insensitivity of Mtb conferred by the
cell envelope and the need subsequently to determine the
mode of action of inhibitors, which can be difficult and time
consuming (Payne et al., 2007). To overcome some of these limi-
tations, target-based whole-cell screening (TB-WCS) has been
developed to identify biologically active inhibitors of prioritized
drug targets (DeVito et al., 2002; Forsyth et al., 2002; Young
et al., 2006). This methodology makes use of conditional mutant
strains in which the expression of a target gene is regulated using
either antisense interference or inducible promoters. Because
reducing the levels of a target should result in a commensurate
increase in the sensitivity of the strain to inhibitors that act on
or biochemically downstream of that target, the assay provides
a simple means to identify inhibitors that are both biologically
active and target or pathway specific. The utility of this approach
in antimicrobial drug discovery is exemplified by the identifica-
tion of platensimycin for use against Gram-positive bacteria
(Wang et al., 2006).
Previous studies have demonstrated that Mtb strains
harboring lesions in the pantothenate synthetase (panC), diami-
nopimelate decarboxylase (lysA), and isocitrate lyase (icl1) locitd All rights reserved
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Pavelka et al., 2003; Sambandamurthy et al., 2002). The essen-
tiality of these genes for the growth and survival of Mtb in vivo
(Hingley-Wilson et al., 2003), together with the lack of human
homologs, makes them potentially attractive targets for antitu-
bercular drug discovery. In this study we used a conditional
expression system based on the tetracycline (Tet)-regulatable
promoter element to generate mutants that conditionally
express panC, lysA, and icl1. We demonstrated the utility of
these strains in confirming the essentiality of these targets for
the growth of Mtb in vitro and showed that conditional silencing
enhanced the sensitivity of Mtb to inhibitors of these targets.
Furthermore, we identified compounds with greater potency
against PanC-depleted than wild-type (WT) Mtb cells in
a proof-of-concept high-throughput screen (HTS) of a small
compound library. Together, our findings illustrate the utility of
conditional mutants as chemical genetic tools to confirm the
mode of action of new compounds and to identify new inhibitors
of mycobacterial growth in a target-based whole-cell format.
RESULTS
Strategy for Constructing Promoter-Replacement
Mutants
To generate conditional mutant strains of Mtb, we employed
a two-step method in which the native promoter of the target
gene was first replaced with a Tet-regulatable promoter element
by single crossover (SCO) homologous recombination, and then
plasmids expressing Tet repressors (TetRs) were introduced
(Ehrt et al., 2005; Guo et al., 2007) (see Figure S1 available on-
line). The suicide plasmids, pPanC-SCO, pLysA-SCO, and
pIcl1-SCO, were introduced into WT Mtb H37Rv, and the corre-
sponding SCO recombinants were identified and genotypically
confirmed (Figure S2). In the absence of TetR, a SCO strain is
dependent on the activity of the Tet-regulated promoter for
expression of its target gene. We observed no significant growth
defects in any of the SCO strains under standard growth condi-
tions. Because the extent of transcriptional silencing required to
confer a growth phenotype was not known for either gene, we
employed three different TetR-expressing vectors that vary in
their mode and/or ability to repress expression from the Tet
promoter. The L5-based integration vectors, pMC1s and
pMC2m, express WT TetR from strong (S) and intermediate
(M)-strength mycobacterial promoters (Guo et al., 2007),
producing conditional mutants in the Tet-ONS and Tet-ONM
configurations, respectively. The higher level of tetR expression
from pMC1s is expected to confer more stringent repression of
the Tet promoter than in cells harboring pMC2m. In contrast,
pTEK-4S-OX is an episomal plasmid that expresses a reverse
TetR (rev TetR) from a strong promoter (Guo et al., 2007). The
activity of rev TetR is lower than WT TetR in mycobacteria (Gan-
dotra et al., 2007; Guo et al., 2007), resulting in less-stringent
repression and higher levels of induced gene expression in the
Tet-OFF configuration. Another issue to be considered when
generating promoter-replacement mutants is the chromosomal
arrangement of the gene under investigation. Placement of the
Tet promoter upstream of a gene present in an operon will also
affect expression of coregulated genes downstream of the
target. This can complicate attempts to correlate the phenotypesChemistry & Biology 19,arising from gene silencing with specific alterations in the levels
of the gene of interest. To circumvent potential off-target effects
arising from promoter replacement in the panC and lysA strains,
we therefore generated complementation vectors to express the
downstream genes in trans from the Tweety attB site (Pham
et al., 2007). These were introduced into the corresponding
SCO strains together with the TetR-expressing vector.
Growth of Mtb Can Be Modulated by Conditional
Depletion of PanC
PanC catalyzes the final step in the biosynthesis of pantothenate
(vitamin B5), an essential precursor of coenzyme A (CoA) and
acyl carrier protein (Webb et al., 2004). panC is considered
essential in Mtb (Sassetti et al., 2003) and, therefore, is predicted
to play an important role in the growth and survival of Mtb in vivo,
particularly during growth on lipid substrates. The importance of
de novo pantothenate biosynthesis in Mtb was confirmed previ-
ously in studies showing that an Mtb pantothenate auxotroph
lacking panC and panD was attenuated in mice (Sambandamur-
thy et al., 2002). We generated conditional panC mutants by
introducing each TetR vector into panC-SCO, together with
pPanC-Comp, and selecting on solid media supplemented
with pantothenate. Conditional mutants harboring both the
TetR and rev TetR-expressing plasmids were obtained. Growth
of the strains on agar supplemented with anhydrotetracycline
(ATc) inducer was attenuated under repressed conditions in
both Tet-ON and Tet-OFF configurations (0 and 200 ng/ml
ATc, respectively) (Figure 1A). Consistent with the relative strin-
gency of repression conferred by the TetR-expressing plasmids,
the growth impairment was most severe in panC Tet-ONS, and
only partially relieved upon addition of ATc at 200 ng/ml. In
contrast, growth of panC Tet-ONM and panC Tet-OFF was highly
titratable at ATc concentrations up to 200 ng/ml. Importantly, the
growth defect of all strains under repressed conditions was
rescued by the inclusion of pantothenate supplement in the
culture medium, confirming that the observed phenotype re-
sulted from a defect in pantothenate biosynthesis. In liquid
culture, growth of panC Tet-ONM and panC Tet-OFF was
severely inhibited by panC silencing (Figures 1B–1E). As
observed on agar, the growth rate of these strains was depen-
dent on the concentration of ATc. In contrast, growth of panC
Tet-ONS correlated poorly with ATc concentration in liquid
culture (Figures S3A and S3B) and, paradoxically, appeared to
be more robust at lower concentrations of inducer. Subsequent
analysis revealed that this was due to the propensity of the panC
Tet-ONS strain to lose Tet-dependent regulation during growth in
liquid culture, particularly at growth-limiting concentrations of
ATc, presumably by the acquisition of suppressor mutations
that alleviate repression. However, such instability was not
readily apparent for the panC Tet-ONM and panC Tet-OFF
strains.
The level of PanC protein produced in the WT, panC-SCO,
panC Tet-ONM, and panC Tet-OFF strains was then assessed
by western blotting. In these experiments, pantothenate was
included in the culture medium to ensure equivalent growth of
the strains. An immunoreactive band corresponding to the pre-
dicted size of the PanC polypeptide (33 kDa) was identified in
cellular lysates from WT Mtb and panC-SCO when probed with
antibodies raisedagainst purified, recombinant PanC (Figure 2A).844–854, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 845
Figure 1. Growth of panC Conditional Mutants Is Highly ATc Dose Dependent
(A) Growth on 7H10 agar is shown. Strains were grown to mid-log phase and equivalent numbers of cells spotted on media containing the indicated concen-
trations of ATc and/or pantothenate.
(B and C) Growth of panC Tet-ONM (B) and Tet-OFF (C) in 7H9 liquid medium supplemented with the indicated concentrations of ATc and/or pantothenate is
presented.
(D and E) Growth of the panC Tet-ONM (D) and panC Tet-OFF (E) mutant strains relative toWTMtb at the indicated ATc concentrations is demonstrated. Data are
from a representative experiment performed in triplicate.
See also Figure S3 and Supplemental Experimental Procedures.
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Tet-OFF and panC Tet-ONM grown under inducing conditions
(0 versus 200 ng/ml ATc, respectively). The level of PanC protein
under these conditions was comparable to that observed in the
WT and panC-SCO strains. However, following panC silencing,
PanC levels dropped to <5% of WT in these mutants, confirming
that the strains behave in a predictable and target-specific
manner in response to inducer treatment (Figures 2A and 2B).
Growth of lysA Conditional Mutants Shows Limited ATc
Dose Dependence
LysA catalyzes the final step in the lysine biosynthetic pathway,
converting meso-2,6-diaminoheptanedioate to L-lysine and is
essential for the growth of Mtb in vitro in the absence of lysine
(Pavelka and Jacobs, 1999). An Mtb lysine auxotroph is severely
attenuated in mice, confirming that the de novo biosynthesis of
this amino acid is essential for growth in vivo (Pavelka et al.,
2003). To generate lysA conditional mutants, the TetR-express-
ing plasmids were introduced into a lysA-SCO together with the
complementation vector, pLysA-Comp, and transformants were
selected under inducing conditions on 7H11 media supple-
mented with 0.05% Tween 80 (Pavelka and Jacobs, 1999).
Viable lysA Tet-ONM and lysA Tet-OFF strains were obtained
and genotypically confirmed (Figure S1). In contrast we could
not isolate a Tet-ONS derivative, suggesting that in this case
the level of lysA expression was below the threshold required
to support bacillary replication. Growth of the conditional
mutants was examined on solid media, with or without ATc.
In accordance with the known essentiality of lysA, the lysA
Tet-ONM strain grew very poorly in the absence of inducer (Fig-
ure 3A). The defect was, however, ameliorated by induction of846 Chemistry & Biology 19, 844–854, July 27, 2012 ª2012 Elsevier LlysA expression at the lowest concentration of ATc tested
(1.5 ng/ml), with only a modest increase in growth observed at
higher concentrations (Figure 3A). The growth defect of this
strain under repressing conditions was also reversed by inclu-
sion of lysine in the growth medium, confirming that it was attrib-
utable to disrupted lysine biosynthesis. Similarly, growth of the
lysA Tet-OFF strain was not significantly affected by ATc-
induced gene silencing, with only minor inhibition observed at
the highest level of inducer (Figure 3A). Although the levels of
lysA expression were not determined, the lack of ATc respon-
siveness in this strain most likely reflects an inability of rev
TetR to regulate gene expression tightly, and rescue of growth
by leaky expression of lysA. In liquid culture, growth of lysA
Tet-ONM was repressed by omission of either inducer or lysine
(Figure 3B) but ameliorated at higher concentrations of ATc or
with lysine supplementation. Interestingly, this strain displayed
greater ATc dose responsiveness of growth in liquid culture
than was apparent on solid media (Figure 3B). However, as
observed on agar, the growth of lysA Tet-OFF was only margin-
ally inhibited following lysA silencing with ATc at 200 ng/ml (Fig-
ure 3C), an effect reversed by lysine supplementation.
Depletion of Icl1 Selectively Impairs Growth of Mtb
H37Rv on Acetate
Icl catalyzes the conversion of isocitrate to glyoxylate and succi-
nate in the first step of the glyoxylate shunt, a carbon assimilatory
pathway that allows the net synthesis of C4 dicarboxylic acids
from C2 compounds such as acetate (Mun˜oz-Elı´as and McKin-
ney, 2006). In Mtb H37Rv, Icl activity is provided by icl1
(Rv0467) (Ho¨ner Zu Bentrup et al., 1999). Enzymes of the glyox-
ylate shunt in Mtb are upregulated during growth on fatty acidtd All rights reserved
Figure 2. ATc-Dependent PanC Depletion in Conditional Mutant
Strains
(A) Western blot probed with PanC antibody (rabbit serum) is illustrated. Lanes
were loaded with 25 ng of purified His-tagged PanC (A.K. and D.R.S.,
unpublished data) (rPanC), molecular weight marker (Bio-Rad precision plus)
(M), or 22.5 mg of whole-cell lysates prepared from WT H37RvMA, panC SCO
(SCO), and panC Tet-OFF or Tet-ONM strains. Cells were grown in the pres-
ence or absence of 200 ng/ml ATc, as indicated.
(B) The average level of PanC in each strain is shown as a percentage of
the level in WT Mtb. The integrated signal intensity of each PanC band
was quantified on a Li-Cor Infrared scanner in three replicate experiments
performed with freshly prepared lysates (except panC-SCO, which was
performed in duplicate).
The error bars represent SDs.
See also Supplemental Experimental Procedures.
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ability of Mtb to grow on such substrates. Icl1 has further been
demonstrated to be essential for growth of Mtb in macrophages,
and during acute and chronic infection in mice (Blumenthal et al.,
2010; McKinney et al., 2000; Mun˜oz-Elı´as and McKinney, 2005).
Conditional icl1 mutants were generated by introducing the
TetR-expressing plasmids into icl1-SCO and selecting under
inducing conditions on media supplemented with glucose and
glycerol. Mutants harboring all three TetR-expressing vectors
were isolated. To examine the effects of icl1 silencing, the strains
were grown in liquid 7H9 medium containing acetate or propio-
nate as the sole carbon source, with or without inducer. None
of the strains grew in propionate, even under fully induced condi-
tions, suggesting that the inferred perturbation in the level of icl1
expression resulting from the promoter replacement rendered
the strain incapable of providing sufficient 2-methylisocitrate
lyase activity to sustain growth in this carbon source (Gould
et al., 2006; Upton and McKinney, 2007). However, all three
conditional mutants grew in acetate under nonrepressing condi-
tions, and the icl1 Tet-OFF strain displayed significant growth
attenuation in response to ATc-induced icl1 silencing on solid
agar containing acetate as the sole carbon source (Figure 4A)Chemistry & Biology 19,but showed no effect upon growth on glucose and glycerol
(data not shown). In contrast, icl1 Tet-ONS and icl1 Tet-ONM
failed to display the anticipated ATc-dependent phenotypes
during growth on acetate, suggesting that Tet regulation of icl1
expression was lost upon propagation of these strains. In liquid
culture, the growth of icl1 Tet-OFF on acetate was significantly
impaired in the presence of ATc but restored by the omission
of inducer (Figure 4B). Similarly, and consistent with the pheno-
types observed for icl deletion mutants of Mtb (Mun˜oz-Elı´as and
McKinney, 2005), icl1 Tet-OFFwas not adversely affected by icl1
silencing when cultured on glucose (Figure 4C), as compared to
acetate (Figure 4B).
Target Depletion Confers Hypersensitivity to
Target-Specific Inhibitors in Mtb
Reducing the expression of a target gene is predicted to sensitize
cells to inhibitors that act on that target. We therefore compared
the susceptibility of icl1 Tet-OFF to the known Icl inhibitor, 3-ni-
tropropionate (3-NP) (Ho¨ner ZuBentrup et al., 1999;Mun˜oz-Elı´as
andMcKinney, 2005),with that ofWTMtb and the icl1-SCOstrain
during growth in glucose- or acetate-containing medium and as
a function of inducer concentration. Susceptibility testing was
performed using the Alamar blue redox indicator. The indicator
is blue in the oxidized state and turns pink upon reduction by
metabolically active cells, thus providing a means of detecting
growth colorimetrically (Yajko et al., 1995). No significant differ-
ences in the susceptibility of the three Mtb strains to 3-NP were
observed during growth on glucose, regardless of the ATc
concentration used (Figure 5A). However, when grown on
acetate, the susceptibility of icl1-SCO to inhibition by 3-NP was
increased 16-fold relative to WT Mtb (Figure 5B). Although not
measured directly, these results suggest that the level of icl1
expression from the Tet-regulated promoter in icl1-SCO is signif-
icantly lower than from the native promoter in WTMtb. The 3-NP
susceptibility of WT Mtb and icl1-SCO was unaffected by Atc,
whereas icl1 Tet-OFF showed an ATc dose-dependent increase
in susceptibility (Figure 5B). In contrast no differential sensitivity
was observed to the antituberculars isoniazid, rifampicin, etham-
butol, streptomycin, and cycloserine, which act on other cellular
targets, during growth of icl1 Tet-OFF on acetate, with or without
ATc (Table S1, top panel). Together, these findings demonstrate
that the whole-cell activity of 3-NP on Mtb is due to specific inhi-
bition of Icl1 and that icl1 silencing does not confer generalized
hypersensitivity to antitubercular drugs.
We then used the panC TetOFF strain to assess the antimicro-
bial activity and target specificity of inhibitors of the Mtb PanC
enzyme developed using fragment-based approaches (Hung
et al., 2009). The susceptibility of panC Tet-OFF to eight PanC
inhibitors wasmeasured in a broth microdilution assay. Although
these inhibitors have KD values of 1.8 mM, none of the
compounds was active against WT Mtb or panC-SCO at
concentrations up to 250 mM. Moreover, in the absence of
ATc, the growth of panC Tet-OFF was not significantly affected
by the presence of inhibitor relative to the carrier (DMSO) control.
However, a marked increase in sensitivity was apparent for all
compounds following panC silencing with ATc (10 ng/ml), with
the most potent inhibitor, Alv553 (Hung et al., 2009) (Figure 5C),
displaying an MIC50 of 31–62 mM (Figure 5D). In all cases the
growth inhibition observed in the presence of ATc was reversed844–854, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 847
Figure 3. lysA Conditional Mutants Show
Limited ATc Dose Dependence for Growth
(A) Growth on 7H10 agar is shown. Strains were
grown to midlog phase and equivalent numbers of
cells spotted on media containing the indicated
concentrations of ATc and/or lysine.
(B and C) ATc dose-dependent growth of lysA
Tet-ONM (B) and Tet-OFF (C) in 7H9 liquid medium
containing ATc and/or lysine at the indicated
concentrations is presented. Data are from a
representative experiment performed in triplicate.
See also Supplemental Experimental Procedures.
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between growth inhibition and pantothenate biosynthesis.
Under identical assay conditions no alteration in the MICs of
known antitubercular drugs was observed (Table S1, top panel).
Moreover, upon silencing of the corresponding target genes,
no increase was observed in the sensitivity of panC Tet-OFF
and icl1 Tet-OFF to noncognate inhibitors, i.e., the Icl- and
PanC-specific inhibitors, respectively. Together, these findings
provide compelling evidence that the PanC enzyme inhibitors
are acting on target to inhibit the activity of PanC in Mtb,
and demonstrate the power of combining fragment-based
approaches and TB-WCS using sensitized Mtb strains.
Fluorescently Labeled Conditional Mutants Are Suitable
for Use in HTS
To generate conditional mutants of Mtb that can be used to
monitor the activity of small molecule inhibitors and are also
compatible with HTS applications, we assessed the suitability
of a fluorescence-based reporter to quantify growth. We cloned
the gfp gene encoding green fluorescent protein (GFP) under
control of the constitutive M. marinum msp12 promoter (Chan
et al., 2002) in the rev TetR-expressing vector used to generate
the Tet-OFF strains. The resulting plasmid was introduced
into icl1-SCO and panC-SCO to produce the corresponding
Tet-OFFGFP derivatives. panC Tet-OFFGFP was indistinguishable
from panC Tet-OFF in terms of growth, ATc-induced gene848 Chemistry & Biology 19, 844–854, July 27, 2012 ª2012 Elsevier Ltd All rights reservedsilencing, and rescue by pantothenate
under repressing conditions on agar (Fig-
ure S4A) and in liquid culture (Figures S4B
and S4C). However, low-background
florescence was observed for panC Tet-
OFF (Figure S4D), whereas panC Tet-
OFFGFP emitted a strong fluorescence
signal (Figure S4E), which correlated well
with growth, as measured by turbidity
(Figure S4B). Similarly, no significant
differences in growth of icl1 Tet-OFF
and icl1 Tet-OFFGFP were observed in
response to ATc-induced silencing on
7H10 agar containing glucose or acetate
as carbon source. The correlation
between growth and fluorescence of icl1
Tet-OFFGFP was assayed during growth
in 7H9 medium containing acetate as the
sole carbon source (Figure S5A). Likeicl1 Tet-OFF, growth of icl1 Tet-OFFGFP was attenuated in the
presence of ATc in this medium but reversed by the omission of
inducer (Figure S5A) or by replacing acetate with a glycolytic
carbon source (Figure S5B). In addition a good correlation was
observed between the fluorescence emitted by icl1 Tet-OFFGFP
(Figures S5C and S5D) and growth, as measured by turbidity
(Figures S5A and S5C). For both reporter strains the inhibitory
activities of known antitubercular drugs, asmeasured by fluores-
cence-based readout, corresponded well with MIC values
determined visually (Table S1, bottompanel). Furthermore, using
fluorescence-based readout, the sensitivities of panC Tet-
OFFGFP to a PanC-specific inhibitor and of acetate-grown icl1
Tet-OFFGFP to 3-NP were shown to increase, as expected, in
the presence of ATc (Figures 6A and 6B, respectively).
HTS Identifies Compounds with Increased Potency
against PanC-Depleted Mtb
The fluorescence-based whole-cell assay for PanCwas adapted
for use in 384-well microplate format for HTS. To validate the
screen, a 600-compound subset of the NCGC library was
screened in quantitative HTS (qHTS) format (Inglese et al.,
2006) against PanC Tet-OFFGFP grown on butyrate, either with
ATc (50 ng/ml), or without inducer. To increase the sensitivity
of the screen, butyrate was selected as a fatty acid carbon
source because it supports growth of Mtb via CoA-dependent
b-oxidation to acetyl-CoA. The PanC inhibitor, Alv553, included
Figure 4. Selective Growth Impairment of
the icl1 Tet-OFF Strain in Acetate
(A) Growth of icl1 Tet-OFF on 7H10 agar contain-
ing 0.1% acetate as the sole carbon source is
demonstrated. The strain was grown to mid-log
phase and equivalent numbers of cells spotted on
media supplemented with the indicated concen-
trations of ATc.
(B and C) Growth of the icl1 Tet-OFF conditional
mutant in 7H9 media supplemented with 0.1%
acetate (B) or glucose (C) in the absence (0 ATc) or
presence (200 ATc) of inducer is illustrated. Data
are from a representative experiment performed in
triplicate.
See also Supplemental Experimental Procedures.
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a hit in the +ATc screen. Based on these results, we proceeded
to screen a larger compound library for activity against panC
Tet-OFFGFP grown on butyrate with ATc in a qHTS format
(Inglese et al., 2006) in which each compound was tested at
seven different concentrations. To identify compounds to which
panC Tet-OFFGFP was specifically hypersensitized, the same
library was screened against WTMtb grown on butyrate (without
ATc), and the results were compared. Compounds possessing
full concentration-response curves (Figure 7A) (Inglese et al.,
2006) and displaying a 10-fold or greater potency (MIC50) against
panC Tet-OFFGFP relative to the WT strain were classified as
screen-selective hits. Of the 37 hits selected according to this
criterion, attention was focused on compounds for which
multiple hits were identified within a class, i.e., 6 flavones and
4 piperazines. The differential activity of these compounds
against PanC Tet-OFFGFP in the presence and absence of
ATc was assessed using the broth microdilution assay. The
piperazines failed to reconfirm in this assay (Figure 7B) and
were thus excluded from further analysis. However, four of
the commercially available flavones, 3,5 dihydroxyflavone, 3,7
dihydroxyflavone, 6-methoxy-apigenin, and apigenin-7-O-neo-
hesperidoside, did reconfirm, with the most active of these
displaying an 16-fold increase in potency against panC Tet-
OFFGFP in the presence of ATc compared to the ATc-free controlChemistry & Biology 19, 844–854, July 27, 2012(Figure 7B). The growth inhibitory effects
of these compounds in the presence of
ATc were also reversed by exogenous
pantothenate, suggesting that the bacilli
were sensitized to disruption of some
cellular process for which pantothenate
is required. To determine if the com-
pounds act directly on PanC, they were
tested in biochemical assays against the
purified recombinant enzyme. However,
none showed inhibitory activity against
the PanC enzyme itself (data not shown).
DISCUSSION
The ability to conditionally regulate the
expression of essential genes has formed
the basis of cell-based assays designedto evaluate the specificity of inhibitors of a given drug target or,
alternatively, to discover new antimicrobial compounds in TB-
WCS (Singh et al., 2007; Wang et al., 2006). This approach is
predicated on the assumption that a reduction in the levels of
an essential target should increase the sensitivity of the host
strain to inhibitors that act on that target or indirectly through
downstream effects of that target. This approach also assays
the target in its native biological environment and samples whole
biochemical pathways as well as related pathways and regula-
tory systems that impinge on that target. In this study we evalu-
ated the utility of a Tet-based conditional expression system for
application in cell-based hypersensitivity assays for three path-
ways in Mtb. PanC, LysA, and Icl1 were selected as test candi-
dates on the basis of their previously demonstrated (conditional)
essentiality for growth and survival of Mtb in vitro and in vivo.
Promoter-replacement mutants were generated by SCO
homologous recombination. Because the extent of target gene
knockdown required to confer a growth phenotype cannot be
predicted a priori and is likely to vary from one gene to the next,
we employed three TetR-expressing plasmids that differ in
regulator mode (forward versus rev TetR) and expression level
(moderate versus strong, and from an integrative [single copy]
versus episomal [multicopy] plasmid) to examine the effects of
varying both the basal and fully induced levels of target gene
expression on the growth of each SCO strain. This strategyª2012 Elsevier Ltd All rights reserved 849
Figure 5. Target Knockdown Hypersensitizes Mtb to Target-Specific Inhibitors
(A and B) icl1 silencing results in hypersensitivity to 3-NP. The susceptibility of WT Mtb, icl1-SCO, and icl1 Tet-OFF to 3-NP inhibition was evaluated at the
indicated concentrations of ATc during growth in media containing either glucose (A) or acetate (B) as the sole carbon source. Bacterial viability wasmeasured by
the Alamar Blue assay in which a transition from a blue to pink color is indicative of growth.
(C and D) The susceptibility of the panC Tet-OFF strain to a representative PanC inhibitor, Alv553, (C) was evaluated (D) in 7H9 medium in the absence (ATc) or
presence (+ATc, 10 ng/ml) of ATc or presence of both ATc and pantothenate (+ATc + P). In each medium the strain was treated with either the experimental
compound (+) or the DMSO carrier alone (). Bacterial growth, as determined by the quantity of bacterial cells settled at the bottom of each well, was assessed
following incubation at 37C for 7 days.
See also Supplemental Experimental Procedures.
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phenotypes corresponding to those obtained by conventional
gene disruption methods. Notably, an icl1 conditional mutant
with a predictable and tightly regulated phenotype was only
generated in a Tet-OFF configuration, and only one conditional
lysA mutant was inducer dependent for growth (lysA Tet-ONM).
Furthermore, whereas a lysA Tet-ONS mutant could not be iso-
lated at all, panC Tet-ONS was viable, albeit unstable in culture.
The failure to isolate viable conditionalmutants in specific genetic
backgrounds, and the propensity of certain strains to lose Tet
regulationwhen propagated in vitro, most likely reflect an inability
to derepress target gene expression sufficiently to sustain
growth. As such, the approach described herein is unlikely to be
equally applicable to all essential targets, and in order to establish
suitability for use in TB-WCS, the behavior of conditional mutant
strains—especially nonauxotrophic strains that cannot be stabi-
lized by supplementation—will need to be individually assessed.
A key consideration in drug target selection is the extent of
target inhibition required before bacterial growth or survival is
impaired (Wei et al., 2011). The genetic approach employed
herein, which permits the phenotypic effects of target gene
expression on bacterial growth to be analyzed at varying levels
of stringency, provides a means to identify those targets whose
activity needs be only partially inhibited by a small molecule
before growth and/or survival is compromised (Carroll et al.,
2011; Woong Park et al., 2011). In the case of PanC, Mtb was
able to grow—albeit at a significantly reduced rate—when the850 Chemistry & Biology 19, 844–854, July 27, 2012 ª2012 Elsevier Llevel of the protein was reduced by >95%, which suggests that
this target may be relatively invulnerable to chemical inhibition.
Drug discovery efforts that target enzymes such as PanC are
therefore likely to require the development of inhibitors suffi-
ciently potent to exert near-complete inhibition of target activity
for growth inhibitory effects to be observed (Wei et al., 2011).
The growth of one icl1 and two panC conditional mutants was
found to be highly amenable to ATc dose-dependent gene
silencing, suggesting that they might serve as useful tools to
identify leads and confirm the mode of action of drugs that act
on these targets. This was demonstrated by the increase in
sensitivity of icl1 Tet-OFF to 3-NP when cultured on acetate at
growth-limiting concentrations of ATc. The sensitization of this
strain was, moreover, limited to a known Icl1 inhibitor during
growth on acetate, consistent with the notion that Icl1 is the
sole or primary target of this compound in Mtb. Similarly,
a specific increase in sensitivity of panC Tet-OFF to PanC inhib-
itors was observed following ATc-induced panC silencing, and
this effect was mitigated by the inclusion of pantothenate in
the growth medium. These findings confirm that the PanC inhib-
itors designed by fragment-based approaches (Hung et al.,
2009) retain their target specificity in whole cells. In a related
study, conditional depletion of LepB was recently shown to
hypersensitize Mtb to a type I signal peptidase inhibitor (Ollinger
et al., 2012); however, the sensitization (2-fold) observed in this
case was markedly lower than for the target/inhibitor couples
described in the present study.td All rights reserved
Figure 6. Fluorescence-Based Evaluation
of the Activity of Target-Specific Inhibitors
(A) The susceptibility of panC Tet-OFFGFP strain to
a target-specific PanC inhibitor was assessed in
7H9 medium in the absence (ATc) or presence
(+ATc, 10 ng/ml) of ATc. Following incubation at
37C for 7 days, the growth of the strain was
measured by fluorescence quantification, and the
relative fluorescence unit (RFU) values were
normalized to growth levels without added drug.
(B) The susceptibility of icl1 Tet-OFFGFP strain to
3-NP inhibition was quantified in the presence
(100 ng/ml) or absence of ATc during growth in
media containing 0.1% acetate as the sole carbon
source. Bacterial viability was measured by fluo-
rescence measurement following incubation at
37C for 7 days.
See also Figures S4 and S5 and Supplemental
Experimental Procedures.
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Target-Based Whole-Cell Screening in MtbBy introducing gfp into the panC and icl1 mutants, we gener-
ated fluorescent reporter strains that could be used to monitor
the activity of antimicrobial compounds in a rapid and quantita-
tive manner. Expression of gfp had no deleterious effects on the
growth kinetics, phenotypes, stability, or susceptibility to known
antituberculars of the conditional mutants used in this study,
suggesting that they have the potential to be used in HTS appli-
cations. A proof-of-concept screen against a small compound
library led to the identification of a series of flavones that dis-
played increased potency against PanC-depleted cells. These
compounds did not inhibit purified PanC directly, suggesting
that they act on another target enzyme in the pathway or on a
target in a related pathway dependent on PanC levels. These
results illustrate the strength of TB-WCS compared to traditional
in vitro enzyme-based screening. Because depletion of an
enzyme target is expected to cause a corresponding decreaseFigure 7. qHTS of the panC Tet-OFFGFP Conditional Mutant
(A) 3D scatterplot of qHTS data either lacking (black) or possessing (blue) conce
(B) Secondary screening of selected qHTS actives against the panC Tet-OFFGFP s
or presence of ATc and pantothenate (+ATc/P) is presented.
See also Supplemental Experimental Procedures.
Chemistry & Biology 19,in the cellular level of its product, conditional mutants may also
be sensitized to inhibitors of enzymes in the same biosynthetic
pathway, e.g., those steps that utilize the target’s product as
substrate. TB-WCS also identifies complex regulatory and allo-
steric molecules that may not be effectively sampled by simple
enzyme screening. Potential targets of the flavones thus include
noncatalytic sites of PanC, enzymes downstream of PanC in
the CoA biosynthetic pathway, and regulators of pantothenate
biosynthesis. In this specific case, CoA-dependent enzymes
may also be rendered hypersensitive to inhibition through CoA
deficiency resulting from PanC depletion. These possibilities,
all of which are consistent with the rescue from inhibition
conferred by exogenous pantothenate, are currently under
investigation. In this regard a widely used method for target
identification is whole-genome sequencing of resistant mutants.
The feasibility of using this approach to identify the target(s) ofntration-response curves is shown.
train in 7H9medium in the absence (ATc) or presence (+ATc, 50 ng/ml) of ATc
844–854, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 851
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Target-Based Whole-Cell Screening in Mtbthe flavones has yet to be established but is expected to depend
on the relative frequencies of mutation of the conditional mutant
to flavone resistance versus loss of ATc-dependent regulation of
panC expression.
In summary the Tet-based promoter replacement has
proven to be useful for both confirming and detecting the
activity of target/pathway-specific inhibitors in whole cells. Our
results demonstrate the power of combining fragment-based
approaches and whole-cell screens using sensitized Mtb strains
to drive TB drug discovery. The approach described here and by
others (Ollinger et al., 2012) should be applicable to a wide range
of mycobacterial targets, regardless of whether biochemical
assays are available or the physiological role(s) of the targets is
known, and may also find broad application in detecting the
activity of compounds that perturb both targets and pathways.SIGNIFICANCE
Conditional mutant strains that underexpress essential
genes have been successfully applied in TB-WCS to identify
antimicrobial compounds that possess activity against
biochemical pathways. In this study we demonstrate the
feasibility of performing TB-WCS in Mtb by using promoter
replacement to generate Tet-responsive mutants that con-
ditionally express panC, lysA, or icl1. Using this method-
ology, we confirmed the essentiality of panC and lysA for
growth of Mtb H37Rv in vitro and as well as the conditional
essentiality of icl1 for growth on fatty acid substrates. Deple-
tion of Icl1 or PanC consequent on ATc treatment rendered
the conditional mutants hypersensitive to target-specific
inhibitors without conferring generalized hypersensitivity
to drugs that act on other targets or pathways. The results
in the case of PanC illustrate the power of combining frag-
ment-based approaches to inhibitor design with whole-cell
screening using strains sensitized to target-specific inhibi-
tors by conditional gene silencing. By introducing GFP
into the conditional mutants, stable reporter strains were
generated for use in HTS. Their utility was demonstrated
by identifying compounds that display greater potency
against a PanC-depleted conditional mutant than WT Mtb
in a proof-of-concept screen of a small compound library.
Rescue from the inhibitory effects of these compounds by
exogenous pantothenate suggests that PanC depletion
sensitized Mtb to disruption of some pantothenate-depen-
dent cellular process. Together, our findings validate the
power of this approach in confirming the mode of action of
antimicrobial agents directly in Mtb cells, and suggest the
potential of TB-WCS to identify small molecule inhibitors
against defined biochemical targets or pathways. TB-WCS
bridges traditional target-based approaches that engage
fully the medicinal chemistry tools of modern drug dis-
covery, and agnostic whole-cell screens that produce the
desired phenotype upfront.EXPERIMENTAL PROCEDURES
Bacterial Growth Conditions
Bacterial growth conditions are described in detail in the Supplemental Exper-
imental Procedures.852 Chemistry & Biology 19, 844–854, July 27, 2012 ª2012 Elsevier LConstruction of Plasmids
The plasmids and primers used in this study are listed in Tables S2 and S3,
respectively, and the procedures used to construct the plasmids are described
in the Supplemental Experimental Procedures.
Construction and Genotypic Characterization of Promoter-
Replacement Mutants
The procedures used to construct and genotypically characterize the
promoter-replacement mutants are described in the Supplemental Experi-
mental Procedures.
Western Blot Analysis
Western blot analysis of the PanC protein in H37RvMA and the panC condi-
tional mutants was performed as described in the Supplemental Experimental
Procedures.
Drug Susceptibility Testing
Drug susceptibility testing was performed using broth microdilution assays, as
described in the Supplemental Experimental Procedures.
Effect of 3-NP on the Growth of the icl1 Tet-OFF Mutant
Cells were grown to OD6000.2 in 7H9medium supplemented with glucose or
acetate as the sole carbon source, and used as an inoculum following 500-fold
dilution in the same medium. A total of 50 ml 7H9 media supplemented with
50 mg/ml Hyg, 25 mg/ml Kan, and ATc, as specified, was added to the remain-
ing experimental wells. Using a starting concentration of 500 mM, 2-fold serial
dilutions were performed for each of the inhibitors. Fifty microliters of cells
were added to each experimental well, to yield a final volume of 100 ml per
well. The plates were incubated at 37C for 7–14 days, and the extent of
growth was determined by the reduction of Alamar Blue (Invitrogen), as spec-
ified by the manufacturer. MIC determinations were performed in triplicate.
Effect of PanC Inhibitors on the Growth of the panC Conditional
Mutants
Cells were grown to anOD600 of0.2 in 7H9medium, and used as an inoculum
following 500-fold dilution in unsupplemented 7H9 medium. Fifty microliters of
7H9 media supplemented with 25 mg/ml Hyg, 12.5 mg/ml Km, and 2.5 mg/ml
Gm in either the absence or presence of 20 ng/ml ATc, or 20 ng/ml ATc and
50 mg/ml pantothenate, was added to the remaining experimental wells. Using
a starting concentration of 500 mM, 2-fold serial dilutions were performed for
each of the inhibitors. Fifty microliters of cells was added to each experimental
well, to yield a final volume of 100 ml per well. The plates were incubated at
37C for 7–14 days, and growth was determined by the visible growth present
in each well. MIC determinations were performed in triplicate for each of the
inhibitors.
qHTS
The NCGC screening library comprises a diverse collection of 13,549 small
molecules designed by the NIH Chemical Genomics Consortium using
commercially available compounds consisting of targeted library chemotypes
focused on proteases, kinases, GPCRs, ion channels, and nuclear receptors;
a diverse collection of ‘‘drug-like’’ compoundswithMW<500, LogP <5; a small
collection of natural product-derived compounds; and a known actives collec-
tion consisting of Sigma’s 1,280-member LOPAC library, a Microsource
collection, a Prestwick library, and a collection from Tocris. For screening of
the library in 384-well format, 13 ml of Middlebrook 7H9 media supplemented
with butyrate as the sole carbon source (H.I.M.B. and C.E.B., details to be
described elsewhere) was dispensed into each of the wells of 384-well, black,
clear-bottomed microtiter plates (Greiner Bio One, Monroe, NC, USA) using
a Biomek FX liquid handler with 384-well dispensing head (Beckman Coulter,
Brea, CA, USA). Rifampicin (50 mg/ml) and DMSO served as positive and nega-
tive controls, respectively, and were included in the first two columns of each
screening plate. Using a 384-well pin tool (V&P Scientific, San Diego, CA,
USA), 130 nl of each screening compound was dispensed into the remaining
wells of the microtiter plate. Mtb cultures were grown to an OD600 of 0.4
and diluted 10-fold in 7H9 media in either the presence of ATc (100 ng/ml),
or absence of inducer, as required, immediately prior to use. A total of 13 ml
of the diluted culture was aspirated into the wells of each plate using thetd All rights reserved
Chemistry & Biology
Target-Based Whole-Cell Screening in MtbBiomek FX liquid handler. Plates were sealed using the ABgene ALP-300
Sealer (ABgene, Surrey, UK) and stored in a plate hotel prior to transfer to
37C. The plates were centrifuged at 3,000 rpm and the seals removed and re-
placed with a Kalypsys stainless steel lid with rubberized gasket (Wako Auto-
mation, Richmond, VA, USA). The lidded microtiter plates were then placed in
a 37C incubator (VWR, Radnor, PA, USA) in stacks of 6; no more than 36
plates were placed in a single incubator. After 72 hr, the plates were removed
from the incubator and the stainless steel lids replaced with plate seals using
the ABgene ALP-300 sealer. The plates were centrifuged briefly (3,000 rpm for
3 s) and read using an EnVision plate reader (Perkin Elmer, Wellesley, MA,
USA), using excitation and emission wavelengths of 485 and 528 nm, respec-
tively. Analysis of compound concentration responses was performed as
previously described by Inglese et al. (2006). Data for each titration point
were normalized relative to the rifampicin (100% inhibition) andDMSOcontrols
(0% inhibition). Concentration-response titration points for each compound
were fitted to the Hill equation to calculate half-maximal activity (IC50) values,
and those compounds possessing full concentration curves (class 1.1, 1.2,
2.1, or 2.2) (Inglese et al., 2006) were selected for further analysis. Confirmatory
screens using the brothmicrodilution assaywere performed using compounds
purchased from Fisher Scientific, Sigma-Aldrich, or Tocris.
Isolation and Purification of Recombinant Mtb PanC
Recombinant PanC was isolated and purified as described in the Supple-
mental Experimental Procedures.
PanC Activity Assay
The activity of recombinant PanC was measured, as previously described
by Zheng and Blanchard (2001). The assay is described in detail in the
Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, three tables, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at http://dx.doi.org/10.1016/j.chembiol.2012.05.020.
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